Thus, for patients who have higher HbA1c at the time of diagnosis, it might be beneficial to use GLP1-M earlier in their course of treatment
We can ask experts for advice, and your story could be featured on Newsweek.
By investing in reliable cold chain solutions and adhering to best practices, pharmaceutical companies can ensure that GLP-1 drugs reach patients in optimal condition, providing the therapeutic benefits they rely on.
Tuttle M.L., Fang J.C., Sarnak M.J., McCallum W
Another factor to be considered is the pharmacological treatments received by a person with diabetes, since certain therapeutic classes appear to have a negative impact on body composition [22,23,24,25]